Cargando…

Diagnostic performance of a computer-assisted diagnosis system for bone scintigraphy of newly developed skeletal metastasis in prostate cancer patients: search for low-sensitivity subgroups

PURPOSE: The computer-assisted diagnostic system for bone scintigraphy (BS) BONENAVI is used to evaluate skeletal metastasis. We investigated its diagnostic performance in prostate cancer patients with and without skeletal metastasis and searched for the problems. METHODS: An artificial neural netwo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koizumi, Mitsuru, Motegi, Kazuki, Koyama, Masamichi, Terauchi, Takashi, Yuasa, Takeshi, Yonese, Junji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Japan 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5517559/ https://www.ncbi.nlm.nih.gov/pubmed/28456877 http://dx.doi.org/10.1007/s12149-017-1175-2

Ejemplares similares

Diagnostic performance of a computer-assisted diagnostic system: sensitivity of BONENAVI for bone scintigraphy in patients with disseminated skeletal metastasis is not so high
por: Koizumi, Mitsuru, et al.
Publicado: (2020)

Bone metastases from breast cancer: associations between morphologic CT patterns and glycolytic activity on PET and bone scintigraphy as well as explorative search for influential factors
por: Sugihara, Tsutomu, et al.
Publicado: (2017)

Comparison between single photon emission computed tomography with computed tomography and planar scintigraphy in sentinel node biopsy in breast cancer patients
por: Koizumi, Mitsuru, et al.
Publicado: (2018)

Metastasizing pleomorphic adenoma in the multiple organs: A case report on FDG-PET/CT imaging
por: Koyama, Masamichi, et al.
Publicado: (2018)

Sinonasal oncocytic Schneiderian papilloma accompanied by intravascular lymphoma: A case report on FDG-PET/CT imaging
por: Koyama, Masamichi, et al.
Publicado: (2016)

A novel biomarker, active whole skeletal total lesion glycolysis (WS-TLG), as a quantitative method to measure bone metastatic activity in breast cancer patients
por: Koizumi, Mitsuru, et al.
Publicado: (2019)

Recent advances in medical therapy for metastatic urothelial cancer
por: Yuasa, Takeshi, et al.
Publicado: (2018)

Therapeutic inhibition of mitochondrial function induces cell death in starvation-resistant renal cell carcinomas
por: Isono, Takahiro, et al.
Publicado: (2016)

A case of gastric metastasis from renal cell cancer during the sequential targeted therapy
por: Uehara, Sho, et al.
Publicado: (2017)

Testicular seminoma with a progressing pulmonary nodule and mediastinal lymphadenopathy without retroperitoneal metastasis
por: Sano, Yuta, et al.
Publicado: (2020)

Unusual metastasis from renal cell cancer after partial nephrectomy and sequential targeted therapy
por: Yasuoka, Shotaro, et al.
Publicado: (2021)

Denosumab: a new option in the treatment of bone metastases from urological cancers
por: Yuasa, Takeshi, et al.
Publicado: (2012)

Biomarkers to predict prognosis and response to checkpoint inhibitors
por: Yuasa, Takeshi, et al.
Publicado: (2017)

Skeletal Metastasis From Carcinoma of the Gall Bladder: Need for Bone Scintigraphy Justified?
por: Aswani, Yashant, et al.
Publicado: (2016)

Skeletal scintigraphy as an important complement for detecting bone metastasis from nasopharyngeal carcinoma
por: Yen, Wei-Jheng, et al.
Publicado: (2022)

Skeletal scintigraphy manifestations of hematologic disorders
por: Solav, Shrikant V, et al.
Publicado: (2012)

Relationship of B7-H3 expression in tumor cells and tumor vasculature with FOXP3+ regulatory T cells in renal cell carcinoma
por: Inamura, Kentaro, et al.
Publicado: (2019)

Organ-specific and tumor-size-dependent responses to sunitinib in clear cell renal cell carcinoma
por: Tsuchiya, Norihiko, et al.
Publicado: (2014)

A case report on (111)In chloride bone marrow scintigraphy in management of adrenal myelolipoma
por: Yamamoto, Tatsuya, et al.
Publicado: (2019)

Long-term complete response of antiandrogen withdrawal syndrome in a patient with metastatic prostate cancer: A case report
por: Sano, Masayuki, et al.
Publicado: (2016)

Abundance of TRAIL attenuated by HIF2α and c-FLIP affects malignancy in renal cell carcinomas
por: Isono, Takahiro, et al.
Publicado: (2018)

Pembrolizumab for a patient with metastatic castration‐resistant prostate cancer with microsatellite instability‐high
por: Fujiwara, Motohiro, et al.
Publicado: (2020)

De novo large‐cell neuroendocrine carcinoma of the prostate: A case report and literature review
por: Fukagawa, Eri, et al.
Publicado: (2022)

Comparison Between Dose-Escalated Intensity Modulated Radiation Therapy and 3-Dimensional Conformal Radiation Therapy for Salvage Radiation Therapy After Prostatectomy
por: Shimoyachi, Nana, et al.
Publicado: (2021)

Development of a new quantification method using partial volume effect correction for individual energy peaks in (111)In-pentetreotide SPECT/CT
por: Yamashita, Kosuke, et al.
Publicado: (2022)

Skeletal Changes in Hypoparathyroidism: X-ray to Bone Scintigraphy
por: Seetharam, SJ, et al.
Publicado: (2020)

A long-term survival case after surgical resection of skeletal muscle metastasis following esophagectomy for squamous cell carcinoma of the esophagus
por: Saito, Akira, et al.
Publicado: (2017)

Prior administration of a non-steroidal anti-androgen failed to prevent the flare-up caused by a luteinizing hormone-releasing hormone agonist in a patient with metastatic prostate cancer
por: Uehara, Sho, et al.
Publicado: (2015)

Improvement of renal function by changing the bone-modifying agent from zoledronic acid to denosumab
por: Yamasaki, Mutsushi, et al.
Publicado: (2016)

Effectiveness and safety profile of pembrolizumab for metastatic urothelial cancer: A retrospective single‐center analysis in Japan
por: Fujiwara, Motohiro, et al.
Publicado: (2021)

A radiological complete response to pembrolizumab in a patient with metastatic upper urinary tract urothelial cancer and Lynch syndrome
por: Oki, Ryosuke, et al.
Publicado: (2022)

Post-operative breast cancer patients diagnosed with skeletal metastasis without bone pain had fewer skeletal-related events and deaths than those with bone pain
por: Koizumi, Mitsuru, et al.
Publicado: (2010)

Evaluation of bone metastatic burden by bone SPECT/CT in metastatic prostate cancer patients: defining threshold value for total bone uptake and assessment in radium-223 treated patients
por: Umeda, Takuro, et al.
Publicado: (2017)

Early onset recall pneumonitis during targeted therapy with sunitinib
por: Yuasa, Takeshi, et al.
Publicado: (2013)

A risk stratification model based on four novel biomarkers predicts prognosis for patients with renal cell carcinoma
por: Kubota, Shigehisa, et al.
Publicado: (2020)

A case of sequential medical therapy for advanced ureteral cancer in Li–Fraumeni syndrome
por: Une, Minami, et al.
Publicado: (2023)

Clinical outcome of patients with pancreatic metastases from renal cell cancer
por: Yuasa, Takeshi, et al.
Publicado: (2015)

Bone Scintigraphy in Staging of Newly Diagnosed Prostate Cancer in Regard of Different Risk Groups
por: Sevcenco, Sabina, et al.
Publicado: (2019)

Inferior vena cava syndrome on skeletal scintigraphy secondary to metastatic prostate cancer
por: Makusha, Lovemore Peter, et al.
Publicado: (2020)

Prostate-specific antigen for prediction of skeletal metastases on bone scintigraphy in prostate cancer
por: Hammond, Emmanuel Nii Boye, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pm75v5vb1dp4t30gamqh6e5kqe